Extra Effects

The CRISPR/Cas9 gene editing approach might not be as precise as previously thought, according to Stanford University's Vinit Mahajan and his colleagues. Mahajan, along with Columbia University's Stephen Tsang, previously used the editing approach to fix the mutation behind retinitis pigmentosa in mice.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.